These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34105364)

  • 1. Pharmacology, polypharmacy and the older adult: a review.
    Robinson P
    Br J Community Nurs; 2021 Jun; 26(6):290-295. PubMed ID: 34105364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of deprescribing for older people with frailty and polypharmacy: part one.
    Lyne S
    Nurs Older People; 2023 Oct; 35(5):35-41. PubMed ID: 37670533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy: the challenge for nurses.
    Kaufman G
    Nurs Stand; 2016 May; 30(39):52-60. PubMed ID: 27224631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frailty and Potentially Inappropriate Prescribing in Older People with Polypharmacy: A Bi-Directional Relationship?
    Randles MA; O'Mahony D; Gallagher PF
    Drugs Aging; 2022 Aug; 39(8):597-606. PubMed ID: 35764865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of medicines optimisation for older people living with frailty.
    Lyne S; McEwan C
    Nurs Older People; 2021 Jun; 33(3):30-35. PubMed ID: 33759404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.
    Hasan Ibrahim AS; Barry HE; Hughes CM
    Fam Pract; 2021 Jul; 38(4):509-523. PubMed ID: 33506870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing trend in hospitalisation due to adverse drug reactions: can we stem the tide?
    Walker LE; Pirmohamed M
    Drug Ther Bull; 2023 Jun; 61(6):87-91. PubMed ID: 37193588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimorbidity and Frailty: Tackling Complexity in Parkinson's Disease.
    Tenison E; Henderson EJ
    J Parkinsons Dis; 2020; 10(s1):S85-S91. PubMed ID: 32741841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-related harm: a geriatric syndrome.
    Stevenson JM; Davies JG; Martin FC
    Age Ageing; 2019 Dec; 49(1):7-11. PubMed ID: 31665207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions in special populations - the elderly.
    Davies EA; O'Mahony MS
    Br J Clin Pharmacol; 2015 Oct; 80(4):796-807. PubMed ID: 25619317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication Management in Frail Older People: Consensus Principles for Clinical Practice, Research, and Education.
    Liau SJ; Lalic S; Sluggett JK; Cesari M; Onder G; Vetrano DL; Morin L; Hartikainen S; Hamina A; Johnell K; Tan ECK; Visvanathan R; Bell JS;
    J Am Med Dir Assoc; 2021 Jan; 22(1):43-49. PubMed ID: 32669236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action.
    Mangin D; Bahat G; Golomb BA; Mallery LH; Moorhouse P; Onder G; Petrovic M; Garfinkel D
    Drugs Aging; 2018 Jul; 35(7):575-587. PubMed ID: 30006810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
    McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
    Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving individualized prescription in patients with multimorbidity through medication review.
    Molist-Brunet N; Sevilla-Sánchez D; Puigoriol-Juvanteny E; Barneto-Soto M; González-Bueno J; Espaulella-Panicot J
    BMC Geriatr; 2022 May; 22(1):417. PubMed ID: 35549672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'It's a job to be done'. Managing polypharmacy at home: A qualitative interview study exploring the experiences of older people living with frailty.
    Previdoli G; Alldred DP; Silcock J; Tyndale-Biscoe S; Okeowo D; Cheong VL; Fylan B
    Health Expect; 2024 Feb; 27(1):e13952. PubMed ID: 39102701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoepidemiology in older people: Purposes and future directions.
    Laroche ML; Sirois C; Reeve E; Gnjidic D; Morin L
    Therapie; 2019 Apr; 74(2):325-332. PubMed ID: 30773343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in older adults: a narrative review of the literature.
    Zazzara MB; Palmer K; Vetrano DL; Carfì A; Onder G
    Eur Geriatr Med; 2021 Jun; 12(3):463-473. PubMed ID: 33738772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
    Tamargo J; Kjeldsen KP; Delpón E; Semb AG; Cerbai E; Dobrev D; Savarese G; Sulzgruber P; Rosano G; Borghi C; Wassmann S; Torp-Pedersen CT; Agewall S; Drexel H; Baumgartner I; Lewis B; Ceconi C; Kaski JC; Niessner A
    Eur Heart J Cardiovasc Pharmacother; 2022 Jun; 8(4):406-419. PubMed ID: 35092425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is polypharmacy beneficial or detrimental for older adults with cardiometabolic multimorbidity? Pooled analysis of studies from Hong Kong and Europe.
    Cheung JTK; Yu R; Woo J
    Fam Pract; 2020 Nov; 37(6):793-800. PubMed ID: 32596732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.